KBRPL2001, a Novel GPR120 Agonist, Improves Insulin Sensitivity and Glucose Tolerance and Decreases Hepatic Steatosis in Rodent Models of Type 2 Diabetes

DIABETES(2016)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要